AFT Pharmaceuticals Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares AFT Pharmaceuticals Ltd with three other
pharmaceutical manufacturers in Australasia:
sales of 107.22 million Australian Dollars [US$75.35 million]
(8.34 million Australian Dollars [US$5.86 million]
of which 100%
was Clinical development), and
Blis Technologies Ltd
(10.64 million New Zealand Dollars [US$6.96 million]
AFT Pharmaceuticals Ltd reported sales of 105.60 million New Zealand Dollars (US$69.11 million)
March of 2020.
increase of 24.0%
versus 2019, when the company's sales were 85.13 million New Zealand Dollars.
Sales at AFT Pharmaceuticals Ltd have increased during each of the previous five years
(and since 2015, sales have increased a total of 88%).
Sales of Southeast Asia saw an increase
that was more than double the company's growth rate: sales were up
130.2% in 2020, from
2.14 million New Zealand Dollars to 4.93 million New Zealand Dollars.
AFT Pharmaceuticals Ltd also saw significant increases in sales in
Rest of World (up 55.2% to 9.13 million New Zealand Dollars)